These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 32719975)

  • 21. Frequency of Comorbidities and Their Association with Clinical Disability and Relapse in Multiple Sclerosis.
    Tettey P; Siejka D; Simpson S; Taylor B; Blizzard L; Ponsonby AL; Dwyer T; van der Mei I
    Neuroepidemiology; 2016; 46(2):106-13. PubMed ID: 26784322
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exploring the role of physical activity and exercise for managing vascular comorbidities in people with multiple sclerosis: A scoping review.
    Ewanchuk BW; Gharagozloo M; Peelen E; Pilutti LA
    Mult Scler Relat Disord; 2018 Nov; 26():19-32. PubMed ID: 30216755
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of comorbidities on the disability progression in multiple sclerosis.
    Maric G; Pekmezovic T; Tamas O; Veselinovic N; Jovanovic A; Lalic K; Mesaros S; Drulovic J
    Acta Neurol Scand; 2022 Jan; 145(1):24-29. PubMed ID: 34414566
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High prevalence of comorbidities at diagnosis in immigrants with multiple sclerosis.
    Rotstein D; Maxwell C; Tu K; Gatley J; Pequeno P; Kopp A; Marrie RA
    Mult Scler; 2021 Oct; 27(12):1902-1913. PubMed ID: 34328821
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recommendations for observational studies of comorbidity in multiple sclerosis.
    Marrie RA; Miller A; Sormani MP; Thompson A; Waubant E; Trojano M; O'Connor P; Fiest K; Reider N; Reingold S; Cohen JA;
    Neurology; 2016 Apr; 86(15):1446-1453. PubMed ID: 26865523
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Headache in the course of multiple sclerosis: a prospective study.
    Gebhardt M; Kropp P; Hoffmann F; Zettl UK
    J Neural Transm (Vienna); 2019 Feb; 126(2):131-139. PubMed ID: 30506270
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Emerging effects of comorbidities on multiple sclerosis.
    Marrie RA; Horwitz RI
    Lancet Neurol; 2010 Aug; 9(8):820-8. PubMed ID: 20650403
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vascular aspects of multiple sclerosis: emphasis on perfusion and cardiovascular comorbidities.
    Jakimovski D; Topolski M; Genovese AV; Weinstock-Guttman B; Zivadinov R
    Expert Rev Neurother; 2019 May; 19(5):445-458. PubMed ID: 31003583
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The utility of administrative data for surveillance of comorbidity in multiple sclerosis: a validation study.
    Marrie RA; Yu BN; Leung S; Elliott L; Caetano P; Warren S; Wolfson C; Patten SB; Svenson LW; Tremlett H; Fisk J; Blanchard JF;
    Neuroepidemiology; 2013; 40(2):85-92. PubMed ID: 23095571
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A systematic review of the incidence and prevalence of autoimmune disease in multiple sclerosis.
    Marrie RA; Reider N; Cohen J; Stuve O; Sorensen PS; Cutter G; Reingold SC; Trojano M
    Mult Scler; 2015 Mar; 21(3):282-93. PubMed ID: 25533299
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polypharmacy in Multiple Sclerosis: Current Knowledge and Future Directions.
    Thelen J; Zvonarev V; Lam S; Burkhardt C; Lynch S; Bruce J
    Mo Med; 2021; 118(3):239-245. PubMed ID: 34149084
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of hypertension, diabetes, hyperlipidemia, and obstructive lung disease on multiple sclerosis disease course.
    Conway DS; Thompson NR; Cohen JA
    Mult Scler; 2017 Feb; 23(2):277-285. PubMed ID: 27230791
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Psychiatric comorbidity is associated with disability progression in multiple sclerosis.
    McKay KA; Tremlett H; Fisk JD; Zhang T; Patten SB; Kastrukoff L; Campbell T; Marrie RA;
    Neurology; 2018 Apr; 90(15):e1316-e1323. PubMed ID: 29523642
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dietary Modification Combined with Nutrition Education and Counseling for Metabolic Comorbidities in Multiple Sclerosis: Implications for Clinical Practice and Research.
    Allogmanny S; Probst Y
    Curr Nutr Rep; 2024 Jun; 13(2):106-112. PubMed ID: 38676838
    [TBL] [Abstract][Full Text] [Related]  

  • 35. InMS: Chronic insomnia disorder in multiple sclerosis - a Portuguese multicentre study on prevalence, subtypes, associated factors and impact on quality of life.
    Viana P; Rodrigues E; Fernandes C; Matas A; Barreto R; Mendonça M; Peralta R; Geraldes R
    Mult Scler Relat Disord; 2015 Sep; 4(5):477-483. PubMed ID: 26346798
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The incidence and prevalence of psychiatric disorders in multiple sclerosis: a systematic review.
    Marrie RA; Reingold S; Cohen J; Stuve O; Trojano M; Sorensen PS; Cutter G; Reider N
    Mult Scler; 2015 Mar; 21(3):305-17. PubMed ID: 25583845
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PSYCHIATRIC DISORDERS IN THE COURSE OF MULTIPLE SCLEROSIS.
    Główczyński P; Błachut M; Zając M; Badura Brzoza KA
    Wiad Lek; 2020; 73(8):1780-1784. PubMed ID: 33055351
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comorbidity was associated with neurologic and psychiatric diseases: a general practice-based controlled study.
    Nuyen J; Schellevis FG; Satariano WA; Spreeuwenberg PM; Birkner MD; van den Bos GA; Groenewegen PP
    J Clin Epidemiol; 2006 Dec; 59(12):1274-84. PubMed ID: 17098570
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The prevalence of Myocardial Infarction among Multiple Sclerosis Patients: a Systematic Review and Meta-analysis.
    Tavallaei MJ; Tavallaei AH; Ebrahimi N; Ghoshouni H; Afshari-Safavi A; Badihian S; Shaygannejad V; Mirmosayyeb O
    Mult Scler Relat Disord; 2021 Nov; 56():103292. PubMed ID: 34634627
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk of Getting COVID-19 in People With Multiple Sclerosis: A Case-Control Study.
    Iaffaldano P; Lucisano G; Manni A; Paolicelli D; Patti F; Capobianco M; Brescia Morra V; Sola P; Pesci I; Lus G; De Luca G; Lugaresi A; Cavalla P; Montepietra S; Maniscalco GT; Granella F; Ragonese P; Vianello M; Brambilla L; Totaro R; Toscano S; Malucchi S; Petracca M; Moiola L; Ferraro D; Lepore V; Mosconi P; Ponzio M; Tedeschi G; Comi G; Battaglia MA; Filippi M; Amato MP; Trojano M;
    Neurol Neuroimmunol Neuroinflamm; 2022 Mar; 9(2):. PubMed ID: 35046084
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.